Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Vedolizumab-4014: A Phase 4, Open-Label Study to Evaluate Vedolizumab IV Dose Optimization on Treatment Outcomes in Nonresponders With Moderately to Severely Active Ulcerative Colitis
Bellaguarda, Emanuelle Araujo Lima
(PD/PI)
Medicine, Gastroenterology Division
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
6/19/18
→
6/19/21
Funding
Quintiles, Inc.
(Agmt 06/19/18)
Takeda Development Center Americas, Inc.
(Agmt 06/19/18)
View all
View less